65
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Decreased mean platelet volume in panic disorder

, , &
Pages 1665-1669 | Published online: 04 Sep 2014

References

  • VanhouttePMPlatelet-derived serotonin, the endothelium, and cardiovascular diseaseJ Cardiovasc Pharmacol199117Suppl 5S6S121717775
  • MarkovitzJHMatthewsKAPlatelets and coronary heart disease: potential psychophysiologic mechanismsPsychosom Med19915366436681758949
  • MercadoCPKilicFMolecular mechanisms of SERT in platelets: regulation of plasma serotonin levelsMol Interv201010423124120729489
  • BakishDCavazzoniPChudzikJRavindranAHrdinaPDEffects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorderBiol Psychiatry19974121841909018388
  • AroraRCMeltzerHYIncreased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patientsLife Sci198944117257342927243
  • RaoMLHawellekBPapassotiropoulosADeisterAFrahnertCUpregulation of the platelet Serotonin2A receptor and low blood serotonin in suicidal psychiatric patientsNeuropsychobiology199838284899732208
  • EspositoMRubertoMPascottoACarotenutoMNutraceutical preparations in childhood migraine prophylaxis: effects on headache outcomes including disability and behaviourNeurol Sci20123361365136822437495
  • PanconesiASerotonin and migraine: a reconsideration of the central theoryJ Headache Pain20089526727618668197
  • LiuHLiuMWangYAssociation of 5-HTT gene polymorphisms with migraine: a systematic review and meta-analysisJ Neurol Sci20113051–2576621450309
  • BorgdorffPTangelderGJMigraine: possible role of shear-induced platelet aggregation with serotonin releaseHeadache20125281298131822568554
  • SarchielliPAlbertiACoppolaFPlatelet-activating factor (PAF) in internal jugular venous blood of migraine without aura patients assessed during migraine attacksCephalalgia200424862363015265050
  • CarotenutoMEspositoMNutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type INeurol Sci201334111905190923532548
  • ScharingerCRablUKasessCHPlatelet serotonin transporter function predicts default-mode network activityPLoS One201493e9254324667541
  • EllisPMSalmondCIs platelet imipramine binding reduced in depression? A meta-analysisBiol Psychiatry19943652922997993955
  • HamiltonSPLinkage and association studies of anxiety disordersDepress Anxiety2009261197698319842169
  • MaronEShlikJSerotonin function in panic disorder: important, but why?Neuropsychopharmacology200631111116132063
  • KaracetinGBayogluBCengizMSerotonin-2A receptor and catechol-O-methyltransferase polymorphisms in panic disorderProg Neuropsychopharmacol Biol Psychiatry201236151022036916
  • CamachoADimsdaleJEPlatelets and psychiatry: lessons learned from old and new studiesPsychosom Med200062332633610845346
  • ParkYSchoeneNHarrisWMean platelet volume as an indicator of platelet activation: methodological issuesPlatelets2002135–630130612189016
  • FirstMBSpitzerRLGibbonMWilliamsJBWStructured Clinical Interview for DSM-IV Axis I Disorders, Clinical Version (SCID-CV)Washington, DCAmerican Psychiatric Press, Inc1996
  • LeschKPBengelDHeilsAAssociation of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory regionScience19962745292152715318929413
  • AharonovitzOGranotYStimulation of mitogen-activated protein kinase and Na+/H+ exchanger in human platelets. Differential effect of phorbol ester and vasopressinJ Biol Chem19962712816494164998663100
  • CookEHFletcherKEWainwrightMMarksNYanSYLeventhalBLPrimary structure of the human platelet serotonin 5-HT2A receptor: identify with frontal cortex serotonin 5-HT2A receptorJ Neurochem19946324654698035173
  • JacksonSRCarterJMPlatelet volume: laboratory measurement and clinical applicationBlood Rev1993721041138369659
  • ThompsonCBLoveDGQuinnPGValeriCRPlatelet size does not correlate with platelet ageBlood19836224874946871471
  • AtaogluACananFMean platelet volume in patients with major depression: effect of escitalopram treatmentJ Clin Psychopharmacol200929436837119593177
  • HausbergMHillebrandUKistersKAddressing sympathetic overactivity in major depressive disorderJ Hypertens200725102004200517885539
  • VizioliLMuscariSMuscariAThe relationship of mean platelet volume with the risk and prognosis of cardiovascular diseasesInt J Clin Pract200963101509151519769707
  • DurmazTÖzdemirÖKeleşTBayramNAAkçayMYeterEPlatelets and sympathetic activity in MITurk J Med Sci2009392259265
  • LandeKGjesdalKFønstelienEKjeldsenSEEideIEffects of adrenaline infusion on platelet number, volume and release reactionThromb Haemost19855424504532417349
  • HjemdahlPLarssonPTWallénNHEffects of stress and beta-blockade on platelet functionCirculation1991846 SupplVI44VI611683610
  • ThompsonCBEatonKAPrinciottaSMRushinCAValeriCRSize dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and functionBr J Haematol19825035095197066203
  • MarazzitiDRossiADell’OssoLDecreased platelet 3H-paroxetine binding in untreated panic disorder patientsLife Sci199965252735274110622283
  • LeschKPWolozinBLMurphyDLReidererPPrimary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporterJ Neurochem1993606231923227684072
  • MartiniCTrincavelliMLTuscanoDSerotonin-mediated phosphorylation of extracellular regulated kinases in platelets of patients with panic disorder versus controlsNeurochem Int200444862763915016478
  • GiretMLaunayJMDreuxCZarifianEBenyacoubKLooHModifications of biochemical parameters in blood platelets of schizophrenic and depressive patientsNeuropsychobiology1980652902967413059
  • WoodKSwadeCAbou-SalehMTCoppenAApparent supersensitivity of platelet 5-HT receptors in lithium-treated patientsJ Affect Disord19858169723156913